Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study.

Esposti LD, Briere JB, Bowrin K, Diego S, Perrone V, Pasquale GD.

Future Cardiol. 2019 Mar;15(2):109-118. doi: 10.2217/fca-2018-0009. Epub 2019 Jan 21.

2.

Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies.

Esposti LD, Perrone V, Sangiorgi D, Buda S, Andretta M, Rossini M, Girolomoni G.

Biologics. 2018 Nov 12;12:151-158. doi: 10.2147/BTT.S168691. eCollection 2018.

3.

Patient characteristics and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban or vitamin K antagonists: real-world evidence from Italian administrative databases.

Ramagopalan S, Allan V, Saragoni S, Esposti LD, Alessandrini D, Perrone V, Buda S, Stynes G, Toma C, DeSolda F; a LHUs group.

J Comp Eff Res. 2018 Nov;7(11):1063-1071. doi: 10.2217/cer-2018-0054. Epub 2018 Aug 13.

4.

Inhalation of peptide-loaded nanoparticles improves heart failure.

Miragoli M, Ceriotti P, Iafisco M, Vacchiano M, Salvarani N, Alogna A, Carullo P, Ramirez-Rodríguez GB, Patrício T, Esposti LD, Rossi F, Ravanetti F, Pinelli S, Alinovi R, Erreni M, Rossi S, Condorelli G, Post H, Tampieri A, Catalucci D.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaan6205. doi: 10.1126/scitranslmed.aan6205.

PMID:
29343624

Supplemental Content

Loading ...
Support Center